Responsibility
As Marketing Authorization Holder (MAH) of the product “Gepsam 500mg/Ademetionine” in the Republic of Lithuania “Vigifarma” is responsible for the product pharmacovigilance in the region. The company kindly asks to inform about an adverse effect immediately over the email info@vigifarma.lt or by phone +370 5 264 0870.